Skip to content
Search

Latest Stories

CCA seeks clear guidance for healthcare settings as government rolls back Covid curbs

Following the prime minister Boris Johnson’s recent announcement about ramping down the Covid-related restrictions in the country, the Company Chemists’ Association has called for a clear guidance for patients and staff in healthcare settings including pharmacies.

On Monday (February 21), Johnson announced in parliament that the legal requirement to self-isolate following a positive Covid test in England would end on Thursday (February 24).


“From this Thursday… we will end the legal requirement to self-isolate following a positive test,” he told MPs.

Raising concerns over the announcement, the CCA said: “Whilst we recognise many people will welcome this latest relaxation of Covid-19 restrictions, the government must now urgently publish guidance on testing and self-isolation for staff in healthcare settings and specifically community pharmacies.

“This will allow pharmacies sufficient time to implement any changes. Pharmacies, like any other healthcare environment, are regularly visited by clinically vulnerable individuals and we want to do our utmost to protect them.”

The association also sought clarity over how the changes would affect the Infection Prevention and Control guidance, “specifically around the use face coverings in healthcare settings for both the public and healthcare workers.”

Zero-tolerance to abuse

Highlighting recent incidents of abusive behavior faced by pharmacists and other staff in pharmacies, the CCA urged the government to set out a zero-tolerance approach to any abuse.

Short supply of lateral flow tests in pharmacies over Christmas pushed pharmacy staff to bear the brunt from frustrated customers.

The CCA stated: “We also need urgent guidance to allow pharmacies to facilitate a smooth withdrawal of lateral flow tests for the non-clinically vulnerable members of the public, ensuring that everybody who wants to can buy a test from 1 April.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less